Facial skin laxity Skin laxity, hyaluronic acid filler, facial lifting
Conditions
Interventions
Patients were injected with hyaluronic acid filler for total 3.3 ml once. Then they were instructed to follow up at immediate, 1, 3, 6, 9 and 12 months after the treatment.
Experimental Drug
Sponsors
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Eligibility
Sex/Gender
All
Age
30 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. aged 30-55 years 2. were diagnosed with mild to moderate skin laxity
Exclusion criteria
Exclusion criteria: 1. Patients who are pregnant or lactating 2. Patients with dermatitis, open wound, or having infection at the area of face 3. Patients who underwent facial lifting within 6 months 4. Patients with serious underlying diseases 5. Patients who received filler injection or thread lift within 12 months 6. Patients who received botulinum toxin injection within 6 months 7. Patients with keloid scar 8. Patients with mental disorders 9. Patients who do not allow photography 10. Patients who received immunosuppressive drugs (e.g. steroids), chemotherapy or Aspirin 11. Patients with history of local anasthesia or hyaluronic acid allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volume change by Vectra Baseline, immediate, 1, 3, 6, 9, 12 months Vectra | — |
Secondary
| Measure | Time frame |
|---|---|
| Physician improvement scale Immediate, 1, 3, 6, 9, 12 months Quartile scale ,Patient improvement scale Immediate, 1, 3, 6, 9, 12 months Quartile scale,Safety Immediate, 1, 3, 6, 9, 12 months Adverse event | — |
Countries
Thailand
Contacts
Public ContactThanya Techapichetvanich
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed